• -€0.50
  • - €0.50

Seki 20 Coated Tablets 10 mg

€6.00
€5.50 Risparmio €0.50
Tax included
Minsan
024427015
100% secure payments
Sorry, no items left.
Quantity
Out-of-Stock

WARNINGS
Sucrose: the tablets contain 48 mg of sucrose per dose; chewable tablets contain approximately 36.8 mg of sucrose per dose; drops contain approximately 140 mg of sucrose per ml. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase isomaltase insufficiency should not take this medicine. In the case of diabetic subjects or those who follow low-calorie diets, it must be borne in mind that the preparation contains sugar. The drops also contain parahydroxybenzoates (E218 and E216) which can cause allergic reactions including delayed type.
PHARMACOTHERAPEUTIC CATEGORY
Cough suppressants, excluding associations with expectorants.
STORAGE
Chewable drops and tablets: this medicine does not require any special storage conditions. Coated tablets: Store at a temperature not exceeding 25 degrees C.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity to the active substance and to any of the excipients.
NAME
SEKI
EXCIPIENTS
10 mg coated tablets: microcrystalline cellulose, silica, talc, magnesium stearate, hypromellose, povidone, macrogol 4000, sucrose, magnesium carbonate, titanium dioxide, erythrosine (E127). 35.4 mg / ml oral drops, suspension: polyoxyethylene stearate, silica, methyl-para-hydroxybenzoate, sucrose, banana flavor, purified water. Children 4.4 mg chewable tablets: sucrose, mannitol, microcrystalline cellulose, starch, methylcellulose, magnesium stearate, talc, strawberry essence.
SIDE EFFECTS
Frequencies of adverse effects: very common (> = 1/10); common (> = 1/100, <1/10); uncommon (> = 1/1000, <1/100); rare (> = 1/10000, <1/1000); very rare (<1/10000), not known. Disorders of the immune system. Not known: anaphylactic / anaphylactoid reaction. Nervous system disorders. Uncommon: drowsiness, dry mouth. Skin and subcutaneous tissue disorders. Not known: urticaria. Pediatrics: Clinical studies and post-marketing surveillance with cloperastine revealed no relevant differences in the nature, frequency, severity and reversibility of adverse reactions between the adult and pediatric population.
PREGNANCY AND BREASTFEEDING
No information is available on the use of Seki in pregnancy. Although the toxicity studies carried out during pregnancy in animals did not show teratogenic activity and fetotoxicity, it is a good prudent rule not to take the drug in the first few months of pregnancy and in the further period only in case of actual need under the direct medical supervision. It is not known whether the drug and / or its metabolites are excreted in human milk; since a risk to the suckling child cannot be excluded, it should not be used during breastfeeding.
INDICATIONS
Cough suppressant.
INTERACTIONS
No interaction studies have been conducted in humans. Concomitant use with: alcohol, antihistamines, anticholinergics, sedatives is not recommended in both adults and children. It is not known whether the extent of the above interactions in pediatric age is similar to that in adulthood. There is no information regarding any drug interactions with laboratory tests. No information is available regarding the interaction of cloperastine with food, therefore it is not recommended to be taken with meals.
DOSAGE
Daily dose. Adults. Coated tablets: 2 tablets in the evening at bedtime; 1 tablet in the morning, 1 tablet in the afternoon, preferably between meals. Drops: 30 drops in the evening before going to bed, 15 drops in the morning, 15 drops in the afternoon. Children. Chewable tablets. Up to 7 years: 2 tablets in the evening at bedtime; one tablet in the morning; one tablet in the afternoon. After 7 years: 4-6 tablets in the evening at bedtime; 2-3 tablets in the morning; 2-3 tablets in the afternoon. Drops: 14 drops in the evening before bedtime, 8 drops in the morning, 8 drops in the afternoon. Under the age of two: proportionally lower doses.
ACTIVE PRINCIPLES
10 mg coated tablets: 10 mg cloperastine hydrochloride. 35.4 mg / ml oral drops, suspension: 100 ml contain 3.54 g cloperastine fendizoate equal to 1.8 g cloperastine; 1 drop (equivalent to 0.05 ml) contains 1.8 mg of cloperastine fendizoate equal to 0.9 mg of cloperastine. Children 4.4 mg chewable tablets: cloperastine fendizoate 4.4 mg.

024427015

Specific References

chat Comments (0)
No customer reviews for the moment.

Seki 20 Coated Tablets 10 mg

€6.00 €5.50